By
James Hataway
Published: Feb. 19, 2015, 9:19 p.m.·
Tags:
Scientific research,
Drug-resistant TB,
HIV coinfection
Athens, Ga. - Researchers at the University of Georgia have developed a new small molecule drug that may serve as a treatment against multidrug-resistant tuberculosis, a form of the disease that cannot be cured with conventional therapies. They describe their findings in a paper published recently in Bioorganic and Medicinal Chemistry Letters.
Read More →